DHCNL — Diversified Healthcare Trust

Summary of DHCNL Q2 2026 Earnings Call

1. Key Financial Results and Metrics

• Normalized FFO: $39 million, or $0.16 per share.
• Adjusted EBITDAre: $82 million.
• Consolidated NOI: Increased 20.4% year-over-year to $84 million.
• Same-property NOI (SHOP segment): Increased 37.2% year-over-year to $52 million, with occupancy rising to 83.1%.
• Same-property cash basis NOI: $83 million, a 20.2% increase year-over-year.
• Liquidity: Approximately $267 million, with net debt to EBITDA improved to 7.1x from 8.7x year-over-year.

2. Strategic Updates and Business Highlights

• Continued operational momentum in the SHOP segment due to strategic changes and operator transitions completed in late 2025.
• New operator agreements are being renegotiated to align legacy partners with a more performance-based fee structure, expected to save $2 million annually starting January 2027.
• Progress on repositioning 16 SHOP communities to convert closed skilled nursing wings into independent living and memory care units, with an initial investment of $20 million expected to yield mid-teens returns.
• Healthy leasing activity in the Medical Office and Life Science portfolio, with same-property occupancy at 95.8%.

3. Forward Guidance and Outlook

• Reaffirmed full-year guidance for total NOI of $307 million to $323 million, with SHOP NOI between $185 million and $195 million.
• Adjusted EBITDAre guidance remains at $300 million to $315 million, and normalized FFO guidance is $0.56 to $0.62 per share.
• Anticipated continued growth in SHOP NOI, although occupancy growth projections have been slightly reduced.

4. Challenges and Points of Concern

• Occupancy Growth: Tracking slightly below initial projections due to transition-related delays, with operators focusing on stabilizing operations rather than aggressively pursuing occupancy.
• Revenue Growth: Although RevPOR is improving, total revenue is impacted by lower occupancy rates.
• Known Vacates: Three known tenant vacates in the Medical Office and Life Science segment represent about 4.6% of annualized revenue, with two effective July 1, 2026.
• Expense Management: While there are improvements, a one-time bad debt charge of $1 million affected rental revenue in the Medical Office segment.

5. Notable Q&A Insights

• Management clarified that the slower top-line growth in the SHOP segment is primarily due to transitional adjustments rather than a lack of focus on revenue generation.
• Future expense synergies are anticipated as new management contracts are implemented, with significant savings already recognized in dietary and maintenance costs.
• Seasonality may impact third-quarter results, particularly with utility costs, but overall guidance remains optimistic.
• The decline in Medical Office/Life Science rental revenue was attributed to a one-time bad debt charge, unrelated to upcoming vacancies.

Overall, DHCNL reported strong financial results driven by effective operational strategies, yet faces challenges with occupancy growth and certain revenue impacts from tenant vacates. The outlook remains positive, supported by strategic initiatives and a focus on improving profitability.